Insiders · DXR

John Jefferies

Chief Medical Officer at Daxor Corp (DXR) since September 2025

John Jefferies has filed 4 insider reports with the SEC since October 2025, as chief Medical Officer at Daxor Corp (DXR). The latest filing, on September 1, 2026, reports grant or award at Daxor Corp (DXR).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where John Jefferies is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Daxor Corp logo
DXR
Daxor Corp
Chief Medical Officersince September 202526,008$8.0391Sep 1, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John Jefferies with

Other insiders at the same companies

Questions about John Jefferies

What is John Jefferies's role at Daxor Corp?
John Jefferies reports to the SEC as chief Medical Officer at Daxor Corp (DXR), according to the latest filing on September 1, 2026.
How many shares does John Jefferies own?
After the latest filing that states it, John Jefferies directly owned 26,008 shares of Daxor Corp (DXR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John Jefferies bought or sold stock recently?
No open-market purchases or sales by John Jefferies are on file. The filings report grant or award and open-market purchase.
How do I get alerts when John Jefferies files?
Follow John Jefferies on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. John Jefferies filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by John Jefferies (SEC CIK 0002086843). Totals count each trade once, skipping amendments whose original is on file, from Oct 2, 2025 on. View on SEC EDGAR · Get this as JSON